Discover how Novartis’s investigational NMDA modulator MIJ821 offers rapid antidepressant effects for treatment‑resistant depression with fewer dissociative, cognitive, and cardiovascular side effects than ketamine and esketamine.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs